New Therapeutic System of Unruptured Intracranial Aneurysms Based on Big Data From Chinese Population

• Conditions: Unruptured Cerebral Aneurysm; Treatment Strategy

• Registration Number: NCT03153865
• Lead Sponsor: Changhai Hospital

Brief Summary

This is a prospective, multicenter, observational study, aiming at comparing the Safety and effectiveness among the different surgical treatment of unruptured intracranial aneurysms in China, so as to improve the diagnosis and treatment of unruptured intracranial aneurysms.

Detailed Description

Not available

Study Timeline

• Status Verified: 2017-05
• Study First Submitted: 2017-05-11
• Study First Submitted QC: 2017-05-12
• Last Update Submitted: 2017-05-12
• Study First Posted: 2017-05-15
• Last Update Posted: 2017-05-15
• Study Start: 2017-06-02
• Primary Completion: 2020-12-31
• Study Completion: 2020-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• patients diagnosed with unruptured intracranial saccular aneurysm on CTA, MRA or DSA.
• patients willing to participate in this clinical trial and attach to regular follow up.

Exclusion Criteria

• intracranial aneurysm correlating to AVM.
• intracranial non-saccular aneurysm.
• the rupture or unrpture of the aneurysm confirmed on CTA、MRA or DSA.
• patients unwilling to participate in this clinical trial and attach to regular follow up.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
mortality and disability	through study completion, an average of 1 year	the rate of death and disable

Secondary Outcome Measures

Name	Time	Method
progression of disease	1 month, 6 months and 1 year after conservative treatment；	enlarge or ruptured of the aneurysm
recurrence rate	1 month, 6 months and 1 year after surgery;

Trial Locations

Locations (1)

Changhai Hospital; 🇨🇳 Shanghai, Shanghai, China